Medexus Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The page contains a questions and answers section for Medexus Pharmaceuticals Inc. The Disclosure score covers 17 United Nations Sustainable Development Goals including: 'Gender Equality', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. The ESG assessment for Medexus Pharmaceuticals Inc represents its reporting of the UN Sustainable Development Goals.
Medexus Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 2.0.
2.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1437 | Valenta Farmatsevtika AO | 2.7 | Medium |
1437 | Wockhardt Bio AG | 2.7 | Medium |
1481 | Medexus Pharmaceuticals Inc | 2.6 | Medium |
1481 | CTI Biopharma Corp | 2.6 | Medium |
1481 | Cannara Biotech Inc | 2.6 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Medexus Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Medexus Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Medexus Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Medexus Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Medexus Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Medexus Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Medexus Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a triamcinolone hexacetonide injectable suspension; and Gleolan, an optical imaging agent indicates for patients with glioma symptoms. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Bolton, Canada.